Dark Forest Capital Management LP Nektar Therapeutics Transaction History

Dark Forest Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.64 - $3.15 $274 - $1,351	429 New	429 $0
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.14 $8,177 - $13,826	2,690 Added 2085.27%	2,819 $9,000
Q2 2022 Aug 15, 2022	BUY	$3.17 - $6.17 $408 - $795	129 New	129 $0
Q1 2022 May 13, 2022	SELL	$4.16 - $13.72 $37 - $123	-9 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$10.83 - $18.41 $509 - $865	-47 Reduced 83.93%	9 $0
Q3 2021 Nov 12, 2021	BUY	$13.07 - $18.84 $731 - $1,055	56 New	56 $1,000

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.